Medical diagnostics company Omega Diagnostics updated the market on its 'VISITECT CD4' development programme on Monday, after its recently-held design review meeting for the test designed to identify advanced HIV disease.
Medical diagnostics company Omega has CE-marked two additional allergens, it announced on Tuesday, extending its menu to 53 allergens which could be run on the fully automated IDS Instrument.
Medical diagnostics firm Omega Diagnostics is to close its German allergy business, Omega Diagnostics GmbH, after failing to find a buyer for the company, management announced on Wednesday.
(WebFG News) - Omega Diagnostics has signed a global distribution agreement with fellow AIM-quoted outfit Immunodiagnostic Systems for its Allersys range of allergy assays.
AIM-listed Omega Diagnostics has signed a supply agreement with a US-based company offering laboratory testing services, specialising in gut health for improved health outcomes.
Medical diagnostics company Omega Diagnostics announced on Tuesday that results for the year to 31 March would be in line with market expectations.
Medical diagnostics company Omega Diagnostics announced an update on its discussions with Immunodiagnostic Systems Holdings on Friday.
Medical diagnostics company Omega announced on Thursday that its fully owned Indian subsidiary, Omega Dx Asia, has received certificates of accreditation from BSI confirming its Quality Management System is compliant with the ISO 9001:2008 and ISO 13485:2003 standards.
Medical diagnostics company Omega Diagnostics posted a trading update for the six months to 30 September on Monday, in advance of releasing its interim results on 21 November.
AIM-listed Omega Diagnostics has secured a £1.8m Scottish Enterprise research and development grant that will help fund the planned expansion of its Allersys range of reagents for use in allergy in vitro diagnostics.
Omega Diagnostics Group is expecting to report an 8% increase in its revenue for the first half of the year.
Shares in Omega Diagnostics were hit hard by the allergy and disease testing company's admission that field tests of its much-anticipated Visitect CD4 test for infectious diseases were likely to be delayed by a stability issue.
AIM-listed medical diagnostics company Omega has cheered with news of its infectious disease and allergy projects.
Shares in Omega Diagnostics were seen as a better investment on Wednesday after a trading update indicated full-year results will be ahead of target and revealed encouraging developments with the product portfolio.
Omega Diagnostics has helped form a new group to connect the mobile and health industries to help meet public health needs in rural areas.
Medical diagnostics company Omega reported a surge in full-year adjusted pre-tax profit after a robust performance from its food intolerance division and said it remains positive about future trading.
Shares in Omega Diagnostics rose after the medical group said it had passed a major milestone in developing its Visitect CD4 HIV blood test.